These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30527640)

  • 1. Drug Policy Research and Health Technology Assessment in Central and Eastern Europe, Western Asia, and Africa: The Interface Between Research Evidence, Policy, and Practice.
    Awaisu A; Niewada M; Greenberg D
    Value Health Reg Issues; 2018 Sep; 16():119-120. PubMed ID: 30527640
    [No Abstract]   [Full Text] [Related]  

  • 2. Health technology assessment in policy and practice. Working group 6 report.
    von Below GC; Boer A; Conde-Olasagasti JL; Dillon A; Gibis B; Grilli R; Hardy C; Liaropoulos L; Martín-Moreno JM; Roine R; Scherstén T; Søreide O; Züllig M
    Int J Technol Assess Health Care; 2002; 18(2):447-55. PubMed ID: 12053429
    [No Abstract]   [Full Text] [Related]  

  • 3. Women, health, and medical technology.
    Stauning I
    Int J Technol Assess Health Care; 1994; 10(2):273-81. PubMed ID: 8034406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTA IN CENTRAL-EASTERN-SOUTHERN EUROPE: FINDING ITS WAY TO HEALTH POLICY.
    Zawada A; Mäkelä M
    Int J Technol Assess Health Care; 2017 Jan; 33(3):331-332. PubMed ID: 29095135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EUR-ASSESS Project Subgroup Report on Dissemination and Impact.
    Granados A; Jonsson E; Banta HD; Bero L; Bonair A; Cochet C; Freemantle N; Grilli R; Grimshaw J; Harvey E; Levi R; Marshall D; Oxman A; Pasart L; Räisänen V; Rius E; Espinas JA
    Int J Technol Assess Health Care; 1997; 13(2):220-86. PubMed ID: 9194353
    [No Abstract]   [Full Text] [Related]  

  • 6. Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making.
    Németh B; Kamusheva M; Mitkova Z; Petykó ZI; Zemplényi A; Dimitrova M; Tachkov K; Balkányi L; Czech M; Dawoud D; Goettsch W; Hren R; Knies S; Lorenzovici L; Maravic Z; Piniazhko O; Zerovnik S; Kaló Z
    J Comp Eff Res; 2023 Apr; 12(4):e220157. PubMed ID: 36861458
    [No Abstract]   [Full Text] [Related]  

  • 7. Diffusion of minimally invasive therapy in Europe.
    Banta HD; Vondeling H
    Health Policy; 1993 Jan; 23(1-2):125-33. PubMed ID: 10171338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A global call for action to include gender in research impact assessment.
    Ovseiko PV; Greenhalgh T; Adam P; Grant J; Hinrichs-Krapels S; Graham KE; Valentine PA; Sued O; Boukhris OF; Al Olaqi NM; Al Rahbi IS; Dowd AM; Bice S; Heiden TL; Fischer MD; Dopson S; Norton R; Pollitt A; Wooding S; Balling GV; Jakobsen U; Kuhlmann E; Klinge I; Pololi LH; Jagsi R; Smith HL; Etzkowitz H; Nielsen MW; Carrion C; Solans-Domènech M; Vizcaino E; Naing L; Cheok QH; Eckelmann B; Simuyemba MC; Msiska T; Declich G; Edmunds LD; Kiparoglou V; Buchan AM; Williamson C; Lord GM; Channon KM; Surender R; Buchan AM
    Health Res Policy Syst; 2016 Jul; 14(1):50. PubMed ID: 27432056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Another special relationship? Interactions between health technology policies and health care systems in the United States and the United Kingdom.
    Sampat B; Drummond M
    J Health Polit Policy Law; 2011 Feb; 36(1):119-39. PubMed ID: 21498797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of health technology assessment on the diffusion of MRI in Australia.
    Hailey DM; Crowe BL
    Int J Technol Assess Health Care; 1993; 9(4):522-9. PubMed ID: 8288428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coverage with evidence development: an examination of conceptual and policy issues.
    Hutton J; Trueman P; Henshall C
    Int J Technol Assess Health Care; 2007; 23(4):425-32. PubMed ID: 17937829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Innovation in health care: the role of HTA in the introduction of new technologies].
    Bührlen B
    Z Evid Fortbild Qual Gesundhwes; 2010; 104(10):703-8. PubMed ID: 21147431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health technology assessment: research trends and future priorities in Europe.
    Nielsen CP; Funch TM; Kristensen FB
    J Health Serv Res Policy; 2011 Jul; 16 Suppl 2():6-15. PubMed ID: 21737525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: Data from the contemporary CLARIFY registry.
    Ferrari R; Ford I; Greenlaw N; Tardif JC; Tendera M; Abergel H; Fox K; Hu D; Shalnova S; Steg PG;
    Eur J Prev Cardiol; 2015 Aug; 22(8):1056-65. PubMed ID: 25147344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Policies in Central and Eastern European Countries.
    Janhz-Różyk K; Kawalec P; Szkultecka-Debek M
    Value Health Reg Issues; 2017 Sep; 13():59-60. PubMed ID: 29073990
    [No Abstract]   [Full Text] [Related]  

  • 16. Technology assessment. Motivation, capability, and future directions.
    Fineberg HV
    Med Care; 1985 May; 23(5):663-71. PubMed ID: 4010354
    [No Abstract]   [Full Text] [Related]  

  • 17. Effective health care and policy action: the example of health visiting.
    Robinson J
    J Adv Nurs; 2000 Dec; 32(6):1315-7. PubMed ID: 11136397
    [No Abstract]   [Full Text] [Related]  

  • 18. Health technology assessment and public health: a time for convergence.
    Battista RN; Lafortune L
    Eur J Public Health; 2009 Jun; 19(3):227. PubMed ID: 19380330
    [No Abstract]   [Full Text] [Related]  

  • 19. World health-related indicators.
    Logan WP
    World Health Stat Rep; 1976; 29(12):682-97. PubMed ID: 1014713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liability, regulation and policy in surgical innovation: the cutting edge of research and therapy.
    Mastroianni AC
    Health Matrix Clevel; 2006; 16(2):351-442. PubMed ID: 16948248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.